Prions: Proteinaceous Infectious Particles and Their Diseases
This paper examines prions — proteinaceous infectious particles — as the proposed causative agents of a family of fatal neurodegenerative disorders known as transmissible spongiform encephalopathies (TSEs). Beginning with the discovery of prions by Stanley Prusiner and the foundational work of Carleton Gajdusek, the paper traces the biology of normal and abnormal prion protein conformations, explains how misfolded PrPSc propagates neurodegeneration, and surveys specific diseases including Creutzfeldt-Jakob Disease, kuru, fatal familial insomnia, and bovine spongiform encephalopathy. It also addresses scientific skepticism of the prion hypothesis, diagnostic approaches, and the current state of treatment and research into antibody and gene therapies.
- Introduction to Prions and Their Discovery: Definition, discovery, and early history of prion research
- Biology of Normal and Abnormal Prion Proteins: Protein folding, PrPC vs. PrPSc, and neurodegeneration mechanism
- Types of Prion Diseases: CJD, kuru, FFI, GSS, and BSE described
- The Prion Hypothesis and Scientific Debate: Evidence for and against the prion hypothesis
- Diagnosis of Prion Diseases: Diagnostic tests including MRI, EEG, and biopsy
- Treatment and Future Research Directions: Current symptom management and antibody or gene therapy research
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper builds understanding progressively — from molecular biology (protein folding, PrPC vs. PrPSc) to clinical presentation, diagnosis, and treatment — giving readers a coherent conceptual arc.
- It presents both sides of a genuine scientific controversy, acknowledging skeptics of the prion hypothesis and their evidence, which demonstrates intellectual balance.
- Historical context is well integrated: the contributions of Gajdusek and Prusiner are woven into the scientific narrative rather than treated as isolated biographical facts.
Key academic technique demonstrated
The paper uses comparison across multiple diseases (kuru, CJD, BSE, FFI, GSS) to establish a pattern of shared pathology, which is a classic technique in biomedical writing for validating a unifying hypothesis. This cross-disease evidence-gathering mirrors how Gajdusek and Prusiner themselves built the prion hypothesis from seemingly disparate clinical observations.
Structure breakdown
The paper opens with a definition and historical background, moves into molecular biology, then catalogs the main prion diseases before addressing scientific controversy. It closes with clinical sections on diagnosis and treatment. This structure — from mechanism to disease to debate to clinical application — is characteristic of a well-organized biomedical overview essay at the undergraduate level.
Introduction to Prions and Their Discovery
Recent cases of Mad Cow Disease have focused public attention on prion diseases and the small proteins believed to cause them. The scientific community has been slow to recognize this mechanism of disease, since prion-caused encephalopathies can demonstrate diverse symptoms and share characteristics with other disorders, such as dementia.
Prions, as the acronym suggests (Proteinaceous Infectious Particles), are small proteins typically expressed in brain tissue that may exist in a normal or abnormal shape. The prion protein is encoded by a gene found on human chromosome 20. Usually, the prion protein is translated in neural tissue, folds into its normal conformation, carries out its cellular role, and is eventually degraded by enzymes. The abnormal prion, however, folds differently from its normal counterpart. This different shape makes it more difficult to degrade and leads to the brain damage seen in patients with prion diseases.
The discovery of prions is credited to Stanley Prusiner, a professor at the University of California, San Francisco School of Medicine. Professor Prusiner coined the term "prion" to describe an apparently new phenomenon of disease transmission and was awarded the Nobel Prize for Medicine in 1997. Prion disease, however, has been documented for centuries in various species. Scrapie, a disease affecting sheep and goats, has been recognized since the 1700s. Similarly, bovine spongiform encephalopathy (BSE) is a progressive neurodegenerative disease that affects cows. Prusiner won the Nobel Prize for his "prion hypothesis," originally published in 1982, although investigation into human prion diseases dates back decades earlier.
Carleton Gajdusek, an American pediatrician, was instrumental in laying the groundwork for Prusiner's prion hypothesis. In the 1950s, Gajdusek studied a rare disease — kuru — that was afflicting the Fore tribe of New Guinea highlanders. He found that the devastating neurodegeneration exhibited by certain members of the Fore tribe could be traced to ritual cannibalism. Autopsied brains of the victims showed a similar type of brain damage to the brains of sheep affected with scrapie. Gajdusek also studied patients with Creutzfeldt-Jakob disease (CJD) and noted that the brain tissue had a similar sponge-like appearance. Based on these apparently diverse diseases, Gajdusek postulated that a new type of infectious agent was responsible. Although the term "prion" did not come into use until the 1980s, Dr. Gajdusek was awarded the Nobel Prize for Medicine in 1976 for the work that linked these disparate afflictions.
References
Inherited prion disease. (n.d.). Retrieved April 21, 2004, from http://www.st-marys.nhs.uk/specialist/prion/factsheets/inheritedpd.htm
Kightly, R. (n.d.). Prion replication and spread at the cellular level. Retrieved April 21, 2004, from Mad Cow Disease Images & BSE Pictures Web site: http://www.rkm.com.au/BSE/index.html
Novak, G. (n.d.). Prions and junk science. Retrieved April 22, 2004, from Science Criticism Web site: http://www.nov55.com/prin.html
Prusiner, S. (2003). The prion diseases. Retrieved April 22, 2004, from Prions Web site: http://www.albany.net/~tjc/prion.html
Roos, R. P. (2001). Controlling new prion diseases. New England Journal of Medicine, 344, 1548–1551.
Sander, D. (2004). Prions. Retrieved April 21, 2004, from All the Virology on the WWW Web site: http://www.tulane.edu/~dmsander/
Secko, D. (2003). Preventing prion disease progression. Retrieved April 21, 2004, from The Scientist Web site: http://www.biomedcentral.com/news/20031103/02/
Somerville, R., & Bolton, D. (2000). Do prions exist? Retrieved April 21, 2004, from Nova Online Web site: http://www.pbs.org/wgbh/nova/madcow/prions.html
Tritz, G. (2000). Prions and viroids. Retrieved April 22, 2004, from Molecular Microbiology Web site: http://www.kcom.edu/faculty/chamberlain/website/lects/Prions.htm
Winklhofer, K., Heske, J., Heller, U., Reintjes, A., Muranyi, W., Moarefi, I., & Tatzelt, J. (2003). Determinants of the in vivo folding of the prion protein. Journal of Biological Chemistry, 278(17), 14961–14970.
Wong, J. (2003). Researchers discover possible diagnosis, treatment, vaccine for mad cow, prion diseases. Retrieved April 21, 2004, from Eurekalert Web site:
Create your account
Always verify citation format against your institution’s current style guide requirements.